These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 14667272)

  • 41. Treatment of advanced non-small cell lung cancer in the elderly.
    Sacco PC; Maione P; Palazzolo G; Gridelli C
    Expert Rev Respir Med; 2018 Sep; 12(9):783-792. PubMed ID: 30092728
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Lung cancer chemotherapy decisions in older patients: the role of patient preference and interactions with physicians.
    Gironés R; Torregrosa D; Gómez-Codina J; Maestu I; Tenias JM; Rosell R
    Clin Transl Oncol; 2012 Mar; 14(3):183-9. PubMed ID: 22374421
    [TBL] [Abstract][Full Text] [Related]  

  • 43. A critical look at the role of chemotherapy in older patients with non-small cell lung cancer.
    Jatoi A; Aranguren D
    J Thorac Oncol; 2007 Jan; 2(1):83-90. PubMed ID: 17410017
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Estimation of an optimal chemotherapy utilisation rate for lung cancer: an evidence-based benchmark for cancer care.
    Jacob S; Hovey E; Ng W; Vinod S; Delaney GP; Barton MB
    Lung Cancer; 2010 Sep; 69(3):307-14. PubMed ID: 20080315
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Desire for Information in the Elderly: Interactions with Patients, Family, and Physicians.
    Gironés R
    J Cancer Educ; 2015 Dec; 30(4):766-73. PubMed ID: 25428838
    [TBL] [Abstract][Full Text] [Related]  

  • 46. An analysis of the outcomes of treatment of small cell lung cancer in the elderly.
    Tebbutt NC; Snyder RD; Burns WI
    Aust N Z J Med; 1997 Apr; 27(2):160-4. PubMed ID: 9145179
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Practice pearls in the management of lung cancer in the elderly.
    Kanesvaran R; Roy Chowdhury A; Krishna L
    J Geriatr Oncol; 2016 Sep; 7(5):362-7. PubMed ID: 27267093
    [TBL] [Abstract][Full Text] [Related]  

  • 48. NSCLC in the elderly--the legacy of therapeutic neglect.
    Weiss J; Langer C
    Curr Treat Options Oncol; 2009 Aug; 10(3-4):180-94. PubMed ID: 19449105
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Originality, benefits and difficulties of clinical research performed by cooperative groups: the experience of an Italian Lung Cancer Study Group.
    Gridelli C; Daniele B
    Crit Rev Oncol Hematol; 2000 Oct; 36(1):3-8. PubMed ID: 10996518
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Current challenges of lung cancer care in an aging population.
    Sacco PC; Casaluce F; Sgambato A; Rossi A; Maione P; Palazzolo G; Napolitano A; Gridelli C
    Expert Rev Anticancer Ther; 2015; 15(12):1419-29. PubMed ID: 26472523
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Selection of Patients in Ongoing Clinical Trials on Lung Cancer.
    Schulkes KJ; Nguyen C; van den Bos F; van Elden LJ; Hamaker ME
    Lung; 2016 Dec; 194(6):967-974. PubMed ID: 27650509
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Caring for the Older Population With Advanced Lung Cancer.
    Presley CJ; Reynolds CH; Langer CJ
    Am Soc Clin Oncol Educ Book; 2017; 37():587-596. PubMed ID: 28561726
    [TBL] [Abstract][Full Text] [Related]  

  • 53. [Elderly patients in clinical trials: new fitness-adapted concepts].
    Goede V; Hallek M
    Internist (Berl); 2007 Nov; 48(11):1232-7. PubMed ID: 17934705
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Clinical aspects of cancer in the elderly. Treatment decisions, treatment choices, and follow-up.
    McKenna RJ
    Cancer; 1994 Oct; 74(7 Suppl):2107-17. PubMed ID: 8087778
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Do Elderly Lung Cancer Patients Aged ≥75 Years Benefit from Immune Checkpoint Inhibitors?
    Takigawa N; Ochi N; Nakagawa N; Nagasaki Y; Taoka M; Ichiyama N; Mimura A; Nakanishi H; Kohara H; Yamane H
    Cancers (Basel); 2020 Jul; 12(7):. PubMed ID: 32708291
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Management of elderly patients.
    Vergnenegre A; Corre R; Lena H; Le Caer H
    Transl Lung Cancer Res; 2013 Jun; 2(3):200-7. PubMed ID: 25806233
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Taxanes in the elderly patient with metastatic breast cancer.
    Yardley DA
    Breast Cancer (Dove Med Press); 2015; 7():293-301. PubMed ID: 26379446
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Psychosocial aspects of cancer in the elderly.
    Walker LG; Köhler CR; Heys SD; Eremin O
    Eur J Surg Oncol; 1998 Oct; 24(5):375-8. PubMed ID: 9800963
    [TBL] [Abstract][Full Text] [Related]  

  • 59. [Chemotherapy of Advanced Non-small Cell Lung Cancer in Elderly Patients.].
    Nie X; Cheng G
    Zhongguo Fei Ai Za Zhi; 2009 Mar; 12(3):244-7. PubMed ID: 20716430
    [No Abstract]   [Full Text] [Related]  

  • 60. The treatment of metastatic non-small cell lung cancer in the elderly: an evidence-based approach.
    Dawe DE; Ellis PM
    Front Oncol; 2014; 4():178. PubMed ID: 25072026
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.